Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
2021 ◽
Vol 149
◽
pp. 82-90
Emmanuelle Jacquet
◽
Ghania Kerouani-Lafaye
◽
Francoise Grude
◽
Sergio Goncalves
◽
Annie Lorence
◽
...
Arnaud Bayle
◽
Antoine Hollebecque
◽
Barbara Pistilli
◽
Christophe Massard
◽
Aurélien Marabelle
Emmanuelle Jacquet
◽
Adrien Monard
◽
Nicolas Albin
2012 ◽
Vol 65
(4)
◽
pp. 705-721
◽
Partha Sarathi Guin
◽
P.C. Mandal
◽
Saurabh Das
2018 ◽
Vol 169
◽
pp. 265-272
◽
Neha Karki
◽
Himani Tiwari
◽
Mintu Pal
◽
Alok Chaurasia
◽
Rajaram Bal
◽
...
2015 ◽
Vol 1086
◽
pp. 73-85
G. Mariappan
◽
N. Sundaraganesan
2018 ◽
Vol 107
◽
pp. 2320-2333
◽
2020 ◽
Vol 21
(1)
◽
pp. 99-106
◽
Nuriye Akev
◽
Eda Candoken
◽
Serap Erdem Kuruca
2014 ◽
Vol 131
◽
pp. 249-260
◽
Hassan M. Badawi
◽
Wolfgang Förner
◽
Shaikh A. Ali
2019 ◽
Vol 26
(8)
◽
pp. 7772-7784
◽
Αnastasia Koltsakidou
◽
Maria Antonopoulou
◽
Εleni Εvgenidou
◽
Ioannis Konstantinou
◽
Dimitra Lambropoulou
2011 ◽
Vol 47
(18)
◽
pp. 5235
◽
Nanda Gopal Sahoo
◽
Hongqian Bao
◽
Yongzheng Pan
◽
Mintu Pal
◽
Mitali Kakran
◽
...